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CASE REPORT 
THREE PREGNANCIES WITH MECHANICAL HEART VALVE 
AND NO FOLLOW-UP IN 10 YEARS 
Raja Parvez Akhtar, Abdul Rehman Abid• and Hasnain Zalar 
ABSTRACT 
Anticoagulation and proper INR (International Normalized Ratio) monitoring is essential for patients having mechanic 
1 heart valves; it is vital in these patients in order to prevent lethal complications such as valve thrombosis and systern~ 
embolism. In pregnancy, it becomes even more important as pregnancy itself is a hypercoagulable state. This repor~ 
describes a female patient having undergone mitral valve replacement with a Starr Edward metallic prosthesis. She carne 
back to the operating surgeon after 10 years of valve replacement with a history of three uneventful healthy deliveries and 
no follow-up and INR monitoring during this period. 
KEY WORDS: Pregnancy. Prosthetic heart valves. Anticoagulation. Rheumatic heart disease. 
INTRODUCTION 
Females are significantly more likely to be affected by 
Rheumatic heart disease (RHO), which is a leading cause. of 
premature morbidity and mortality in Pakistan with a 
prevalence of 5.7 in 1000.1 There is no ideal prosthetic valve. 
All have some advantages and disadvantages. Whenever 
possible, is repaired or replaced with a metallic prosthesis. A 
bioprosthetic valve in young age deteriorates rapidly and the 
patient will need a re-operation. The metallic prosthesis has 
the hazards of anticoagulation but the valve lasts longer 
avoiding a second operation. Women having a mechanical 
heart valve implanted are at a high risk of thrombo-
embolism-"' Furthermore, pregnancy is a hypercoagulable 
state, characterized by increased levels of clotting factors and 
of fibrinogen and platelet adhesiveness.< Anticoagulation is 
necessary for mechanical heart valves in order to prevent 
lethal complications such as valve thrombosis and systemic 
embolism. Even with anticoagulation 7.5-23% of pregnant 
patients with mechanical prostheses can have 
thromboembolic events.s which requires follow-up. 
This case report describes a young woman with metallic valve 
prosthesis and having three uneventful pregnancies, without 
any cardiac follow-up. 
CASE REPORT 
A 26 years old female patient underwent emergency 
mitral valve replacement secondary to severe mitral stenosis 
and regurgitation postpercutaneous transvenous mitral 
commissurotomy (PTMC) in 1996. She had a history of 
rheumatic fever for 7 years and was taking rheumatic fever 
.............................. 
Department of Cardiac Surgery, Punjab Institute of Cardiolog~ Lahore, Pakistan. 
•Department of Cardiology, Punjab Institute of Cardiology, Lahore, Pakistan. 
............................................... 
Correspondence: Dr. Raja Parvez Akhtar, Associate Professor of Cardiac 
Surgery, Punjab lnstituie of Cardiology, Ghaus-ui-Azam Road, Lahore, 
· Pakistan. Email: rajapakhtar@gmail.com 
Received December 26, 2006; accepted April 03, 2007. 
292 
prophylaxis since then. Patient underwent valve replacement 
with 28 mm Starr-Edward's Prosthetic heart valve Model6120 
Edwards Life Sciences (Baxter Healthcare, Edwards CVS 
Division, Santa Ana, CA, USA). She had an uncomplicate<i 
hospital stay and was discharged on 7th post operative day 
with an advice to follow-up in the outpatient clinic for 
anticoagulation management. On discharge, she was placed 
on 5 mg of Wafarin daily. The patient never showed up for 
follow-up or INR monitoring to the hospital. She belonged to 
a far flung area and was repeatedly contacted by mail sent to 
her home address. She never replied and was considered lost 
to follow-up and presumed dead in the surgical database of 
the surgeon. 
After 10 years of the operation, one day she came to the 
author's outpatient clinic with a complaint of pain in 
abdomen, which was bothering her for few days. On systemic 
inquiry, she told the surgeon of three deliveries which were 
conducted at her home by a lady health visitor uneventfully. 
She had continued with the same warfarin dose i.e. Smg per 
day during her pregnancies and never had a bleeding episode 
as thromboembolic complication. She gave birth to one son 
and two daughters. The children were examined by a 
consultant paediatrician who confirmed that they were 
healthy and had no signs of coumadin embryopathy on 
detailed examination. 
Complete work-up was done for her pain in abdomen and it 
turned out to be non-specific abdominal colic. The 
international normalized ratio (INR) was surprisingly 51111 
within the therapeutic range. A transthoracic echocardiogra~ 
was done, which revealed a normally functiOning metalhC 
prosthesis at mitral position with no evidence of thrombosis or 
prosthetic or periprosthetic leak with normal other valvesi 
Transesophageal echocardiogram confirmed the findmgs ~­trans~h?.:acic exa~ination an~ also :~veale~ norm~\{~ 
functwnmg prosthet1c valve at m1tral posthon (Ftgure 1). . 
d wa' was continued on the same dose of warfarin an 
counseled for regular follow-up. 
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1: Transesophageal echocardiographic image of adequately 
prosthetic valve. 
: LV: Left ventricle, Arrow: Starr Edwards prosthetic valve at 
U<,UII\atJc heart disease is one of the leading causes of 
em,ltUire morbidity and mortality.l Females of child-bearing 
significantly more likely to be affected.! The ideal type 
valve replacement for young women is unresolved.2 
with mechanical prosthetic valves are at a high risk of 
~~orriboE,mlbolisnl. Warfarin use in pregnancy is associated 
a low risk of maternal thromboembolic complications but 
d~:;~'~;~losses.' Unfractionated heparin therapy significantly 
i fetal outcome, but upto a third of pregnant women 
mechanical valves have thromboembolic complications, 
imcluctmg fatal events.s 
patient continued the initially prescribed dose of warfarin 
her pregnancies without any monitoring of INR and 
no untoward event occurred. We have not come across 
other such case in the literature. Inspite of all the 
!m•ms.eli11g, we still have patients who do not come for follow-
up or are irregular. The follow-up of more than 500 patients is 
This is the only case in which the patient was not seen 
discharge and she did not see a doctor also. Sharma et a/.6 
reported two pregnant patients, one having prosthetic 
the mitral position while undergoing delivery 
because of thrombosed valve. The oral 
pntlco;,gtllaJlt was discontinued and she was put on adequate 
of Intravenous heparin therapy. The second patient had 
lun<,ve•otf1Jl delivery.' 
et a/. have reported a patient of prosthetic heart valve 
did not take oral anticoagulation for 20 years and still had 
I normally functional metallic aortic prosthesis. Although for 
prosthetic heart valves, it seems impossible to function 
Without any medication, a few examples on the contrary to 
this widely known fact have been reported in the literature? 
Three cases have been reported with a long survival without 
anticoagulation therapy after metallic valve replacement. a 
For these non-compliant patients, a promising solution could 
be self-management techi\ique suggested by Koertke et a/9 
in the ESCAT (Early Self-Controlled Anticoagulation Trial) 
1 and 2 trials. Both these trials showed the benefit of this 
technique with lower INR values.9 Christensen et al.lO have 
also advocated for self-management of anticoagulant therapy 
in patients with mechanical heart valves. It is hoped that 
patients' compliance can be improved if they are adequately 
trained for self-management of their INR values. However, in 
a country like Pakistan, with problem of poverty and illiteracy, 
the option of self-management is less feasible. 
For adequate managem~nt of patients with mechanical heart 
valves, the key factor is compliance to follow-up, which 
requires counseling for the prevention of untoward 
complications of anticoagulation . 
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